Compare this to chemotherapy. With chemo they are trying to balance between killing the patient or killing the cancer. After the trauma of the chemo? The patient might get another week or two of life
Azer -Cel treating incurable patients. Just wait till we get updated results from Cohort B.
Whilst many would like to see more data, IMU will be using this data to support the opening of a NDA file to trial Azer-Cel Oncarlytics combo.
News is probably very close on both the FT & ODD for Azer-Cel and the Ph1B trial for the combo.
This is where the big bucks will come from. This will have all the attention of Big Pharma
.
LC is doing Rockstar science here.
IMU Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)